Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)

The summary for the Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed): The purpose of the Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) Funding Opportunity Announcement (FOA) is to facilitate the translation of vaccine candidates into early clinical testing. The IPCAVD program is designed to enable a multi-disciplinary team to complete necessary steps from final down-selection of an advanced vaccine candidate through regulatory submissions needed for clinical trial(s). These steps include technology transfer, process development, optimization, assay development and qualification, analytical testing, cGMP manufacture, quality assurance oversight, safety testing, product release, drug substance and drug product stability testing program, IND-enabling studies, and regulatory submissions. This FOA will not provide funds for conducting the clinical studies; applicants are encouraged to collaborate with NIAID-supported clinical trial networks or to develop other relationships to support the clinical studies.
Federal Grant Title: Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-20-120
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.855
CFDA Descriptions: Information not provided
Current Application Deadline: March 9th, 2022
Original Application Deadline: March 9th, 2022
Posted Date: March 3rd, 2020
Creation Date: March 3rd, 2020
Archive Date: April 14th, 2022
Total Program Funding:
Maximum Federal Grant Award: $3,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: March 4th, 2020
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-20-120.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
• Immune Tolerance Network (UM1 Clinical Trial Required)
• Accelerating Research and Development of Next Generation Vaccines against Malaria - a Mode...
• Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
• Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
• Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
• Center for HIV/AIDS Vaccine Immunology (CHAVI)
• Genomics of Transplantation Cooperative Research Program
• Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health
• Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...
• Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
• NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
• Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
• Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com